Our annual ranking of America's largest corporations

324 of 500
BACKNEXT
324. Gilead Sciences
Financials: Latest Results
Rank: 324 (Previous rank: 444)
CEO: John C. Martin
Compare tool: Gilead Sciences vs. Top 10
Subscribe to Fortune Magazine
Is Gilead Sciences a great company, or what?
Key financials $ millions % change
from 2008
Revenues 7,011.4 31.4
Profits 2,635.8 31.1
Assets 9,698.6
Stockholders' equity 6,367.1
Market value (3/26/2010) 40,959.2
Profits as % of  
Revenues 37.6
Assets 27.2
Stockholders' equity 41.4
Earnings per share  
2009 $ 2.82
% change from 2008 34.3
1999-2009 annual growth rate % N.A.
Total return to investors %
2009 -15.4
1999-2009 annual rate 29.0
Industry: Pharmaceuticals
Rank Company 500
rank
Revenues
($ millions)
1 Johnson & Johnson 33 61,897.0
2 Pfizer 40 50,009.0
3 Abbott Laboratories 75 30,764.7
4 Merck 85 27,428.3
5 Eli Lilly 112 21,836.0
6 Bristol-Myers Squibb 114 21,634.0
7 Amgen 159 14,642.0
8 Gilead Sciences 324 7,011.4
9 Mylan 412 5,092.8
10 Genzyme 458 4,515.5
11 Allergan 459 4,503.6
12 Biogen Idec 471 4,377.3
Issue date: May 3, 2010.
Galleries and videos
Interactives
  • A changing landscape
    See how revenues and profits at America's 25 largest companies have risen and fallen over the past decade.
  • Watch Wal-Mart grow
    From a single store in 1962 to more than 4,300 outlets today, see how the biggest retailer has expanded.
Headquarters
MAPS
Gilead Sciences
333 Lakeside Dr.
Foster City, CA 94404
650-574-3000
www.gilead.com
Find your top companies
 High revenue growth  High profit growth
 High EPS growth  High return to investors
 Top 5 in its industry  Best company to work for
 Big employer  Small employer



Video

Rank # of Fortune 500 Companies
California 57
Texas 57
New York 56
Company 2009 $ (millions)
Exxon Mobil $19,280.0
Microsoft $14,569.0
Wal-Mart Stores $14,335.0
FAQ and methodology
Included in the survey are U.S. incorporated companies filing financial statements with a government agency. This includes private companies... More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.